{"wdi-IC.FRM.RSDV.ZS": {"data": {"2010": {"ATG": 22.9, "BHS": 28.4, "BRB": 33.7, "BLZ": 4.8, "DMA": 12.1, "DOM": 27.3, "GRD": 27.4, "GUY": 46.1, "JAM": 20.4, "KNA": 30.2, "LCA": 9.9, "VCT": 30.1, "SUR": 4.3, "TTO": 12.4}, "2015": {"PNG": 21.5, "SLB": 20.0, "TLS": 22.2}, "2016": {"DOM": 5.7}, "2018": {"SUR": 19.7}, "recentValue": {"ATG": "2010", "BHS": "2010", "BRB": "2010", "BLZ": "2010", "DMA": "2010", "DOM": "2016", "GRD": "2010", "GUY": "2010", "JAM": "2010", "PNG": "2015", "SLB": "2015", "KNA": "2010", "VCT": "2010", "LCA": "2010", "SUR": "2018", "TLS": "2015", "TTO": "2010"}, "recentYear": {"ATG": "2010", "BHS": "2010", "BRB": "2010", "BLZ": "2010", "DMA": "2010", "DOM": "2016", "GRD": "2010", "GUY": "2010", "JAM": "2010", "PNG": "2015", "SLB": "2015", "KNA": "2010", "VCT": "2010", "LCA": "2010", "SUR": "2018", "TLS": "2015", "TTO": "2010"}}, "def": "Percent of firms that spend on research and development.", "name": "Firms that spend on R&D", "source": "World Bank, Enterprise Surveys (http://www.enterprisesurveys.org/).", "dataset": "World Bank, Enterprise Surveys (http://www.enterprisesurveys.org/).", "category": "Private Sector & Trade", "subcategory": "Business environment", "link": "https://data.worldbank.org/indicator/wdi-IC.FRM.RSDV.ZS", "dim": "none", "priority": "1.0", "units": "% of firms"}, "confidenceIntervals": {"2010": {"BRB": 33.7, "LCA": 1.4142857142857144, "VCT": 3.0100000000000002, "TTO": 12.4}, "2015": {"SLB": 2.0}, "2016": {}, "2018": {}, "recentValue": {"BRB": 287.14285714285717, "BLZ": 2010.0, "DMA": 2010.0, "VCT": 502.5, "TTO": 201.0}}, "featureImportances": {"indicators": {"ihme-skin-and-subcutaneous-diseases": 0.484, "wdi2-SG.VAW.BURN.ZS": 0.328, "hdr-121206": 0.298, "paris-62": 0.017, "wdi-GC.TAX.YPKG.CN": 0.376, "igrac-twap_ind_sids_humandepgwindustry": 0.535, "ihme-liver-cancer-due-to-other-causes": 0.796, "wdi-IT.MLT.MAIN": 0.284, "ihme-sexually-transmitted-infections-excluding-hiv": 0.369, "igrac-twap_ind_sids_ecosystdepgw": 0.086}, "categories": {"Chronic kidney disease": 0.467, "Cardiomyopathy and myocarditis": 0.067, "Mobility and communication": 0.835, "Exposure to mechanical forces": 0.901}}}